We achieve this through our flexible, integrated and tailored services that span all the drug development phases, including regulatory affairs, pharmacovigilance, clinical development and combined medical services.
Headquartered in Hampshire, UK, we have an established worldwide network with office locations in the EU, USA and Japan.
For nearly 25 years, our experts have dedicated their time to supporting the progression of life-saving treatment solutions for rare diseases. These diseases are often neglected, which is why it’s our mission — indeed our passion — to offer drug discovery and development solutions in this area.
If you’ll be at one of these events and would like to arrange a meeting to find out how we can support you, get in touch.
3–6 February 2025
Orlando, FL, USA
01-02 April 2025
LONDON, UK
22-24 April 2025
Boston, USA
29-30 April 2025
Burlington, MA, USA
14-15 May 2025
Burlingame, CA, USA
20-21 May 2025
King of Prussia, PA, USA
16–19 June 2025
Boston, MA, USA